Start with the complete document set
“Botox” is a brand name commonly used in searches, while a clinic may use one or more prescription botulinum toxin products. The protocol and every related form should identify the actual product used and reflect its current FDA-approved labeling and the clinic’s authorized practice.
Clinical protocol
Scope, roles, eligibility, preparation, approved workflow, documentation, aftercare, follow-up, and escalation.
Orders and authorization
Patient-specific orders, standing orders, delegation, or supervision documents required for the clinic’s state and team.
Patient forms
Intake, consent, pre-care instructions, aftercare, photography authorization where used, and contact guidance.
Operational records
Treatment record, product and lot tracking, inventory and storage logs, cleaning checklist, incident record, and version history.
Core sections of the clinical protocol
Purpose, scope, and approved services
Name the treatment category, clinic setting, intended use, service boundaries, and products covered. Separate cosmetic and therapeutic services when their evaluation and documentation differ.
Provider roles and clinical authority
Define who evaluates, diagnoses, orders or prescribes, performs treatment, provides supervision, and responds to complications according to state law and licensure.
Patient evaluation and eligibility
Organize relevant history, medication and allergy review, prior treatment response, contraindication review, baseline findings, treatment goals, and referral or deferral criteria.
Product-specific preparation and workflow
Reference the current prescribing information, manufacturer instructions, clinic-approved supplies, storage, handling, reconstitution where applicable, and aseptic technique. Qualified leadership must approve clinical parameters.
Consent, documentation, and photographs
Coordinate risk discussion, alternatives, patient questions, authorization, standardized mapping, product traceability, and photography practices with privacy and records policies.
Aftercare, follow-up, and escalation
Define routine education, expected and concerning symptoms, communication channels, follow-up timing, urgent evaluation, emergency response, reporting, and continuity of care.
What belongs in the treatment record?
- Patient identifiers and date of service
- Treating and ordering professionals
- Assessment and treatment indication
- Consent confirmation
- Exact product and formulation
- Lot number and expiration date
- Preparation and traceability details
- Anatomic sites and treatment mapping
- Total amount documented in product-specific units
- Patient response and unexpected events
- Aftercare and return precautions provided
- Follow-up plan and communications
Doses, dilution or reconstitution, treatment sites, and other clinical parameters must be product-specific and approved by qualified clinical leadership using current labeling, evidence, training, and individual patient judgment.
Why product specificity matters
The FDA prescribing information for BOTOX Cosmetic states that potency units are specific to the preparation and are not interchangeable with other botulinum toxin products. A clinic using multiple brands should avoid a single generic field or conversion assumption. Product name, concentration, preparation, units, storage, lot tracking, and labeling references should remain distinct.
Source verification
Record approved suppliers and processes for detecting questionable or counterfeit product.
Storage and handling
Match the current label and manufacturer instructions, including what the clinic does when conditions fall outside limits.
Traceability
Connect inventory, preparation, lot and expiration details, treating provider, patient record, and any adverse-event report.
Separate instructions
Keep brand-specific information distinct rather than treating all neuromodulators as equivalent.
Build safety into the workflow
The protocol should connect infection prevention, emergency readiness, complication recognition, transfer or referral, reporting, and follow-up. CDC safe injection guidance includes aseptic technique and a new sterile needle and syringe for every injection; the clinic’s detailed policy should also address medication preparation areas, sharps, exposure control, and waste.
The current product label and patient-specific assessment should drive warnings and escalation instructions. Team members need clear direction for symptoms that require prompt clinical review or emergency services and must know how to reach the responsible clinician.
Review before use
Before implementation, reconcile the protocol, standing orders, consent, treatment record, aftercare, and emergency plan. Confirm that provider titles are precise, product references are current, all forms capture the same information, and approval and review dates are documented.
Selected authoritative resources
Frequently asked questions
Can one protocol cover every neuromodulator brand?
A shared framework may be possible, but product-specific labeling, units, preparation, storage, documentation, and warnings must remain clear. Products should not be treated as interchangeable.
Should a template include doses?
A purchased template should not establish patient care. Clinical parameters require product-specific approval by an authorized professional and patient-specific judgment.
What other forms are needed?
Common supporting documents include intake, consent, treatment record and mapping, aftercare, product tracking, cleaning and setup checklists, incident documentation, and applicable orders.
Who approves the final protocol?
The purchasing clinic’s appropriately qualified medical director, supervising provider, prescriber, and other required professionals should complete final review and approval.
Build a clinic-specific neuromodulator package.
Organize your protocol, applicable orders, patient forms, treatment record, SOPs, aftercare, checklists, and safety materials around your state, providers, products, branding, and workflow.
Build My Protocol